1. Cytotoxic effects of curcumin on osteosarcoma cell lines

   • Denise K. Walters
   • Roman Muff
   • Bruno Fuchs

   PRECLINICAL STUDIES 11 December 2007 Pages: 289 - 297

   

2. Identification of small molecules inducing apoptosis by cell-based assay using fission yeast deletion mutants

   • Kyung-Sook Chung
   • Nam-Hui Yim
   • Misun Won

   PRECLINICAL STUDIES 19 January 2008 Pages: 299 - 307

   

3. The combination of gamma ionizing radiation and 8-Cl-cAMP induces synergistic cell growth inhibition and induction of apoptosis in human prostate cancer cells

   • Vesna Vučić
   • Ana Nićiforović
   • Sabera Ruždijić

   PRECLINICAL STUDIES 04 December 2007 Pages: 309 - 317

   

4. Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine

   • Ashish Aggarwal
   • Anna Kruczynski
   • Sharon Lobert

   PRECLINICAL STUDIES 11 December 2007 Pages: 319 - 330

   

5. A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia

   • Wendy Stock
   • Samir D. Undevia
   • Francis J. Giles

   PHASE I STUDIES 19 April 2008 Pages: 331 - 338

   

6. Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancer

   • Daniel G. Stover
   • A. Craig Lockhart
   • Mace L. Rothenberg

   PHASE I STUDIES 08 May 2008 Pages: 339 - 345

   

7. Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies

   • Priscila H. Goncalves
   • Francine High
   • Patricia M. LoRusso

   PHASE I STUDIES 01 May 2008 Pages: 347 - 354

   

8. Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles

   • Sharon L. Sanborn
   • Matthew M. Cooney
   • Scot C. Remick

   PHASE I STUDIES 10 May 2008 Pages: 355 - 362

9. Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer

   • Faruk Tas
   • Nese Guney
   • Erkan Topuz

   PHASE II STUDIES 29 December 2007 Pages: 363 - 368

   

10. A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas

    • Steven Attia
    • Jill Kolesar
    • Kyle D. Holen

    PHASE II STUDIES 16 February 2008 Pages: 369 - 379

    

11. A phase II study of pemetrexed in patients with advanced hepatocellular carcinoma

    • Allen L. Cohn
    • J. William Myers
    • Lina Asmar

    PHASE II STUDIES 28 February 2008 Pages: 381 - 386

    

12. Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma

    • Byeong-Bae Park
    • Young-Hyuck Im
    • Keunchil Park

    PHASE II STUDIES 27 March 2008 Pages: 387 - 392

    

13. Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation

    • J. Tol
    • A. Cats
    • C. J. A. Punt

    PHASE III STUDIES Open access 12 March 2008 Pages: 393 - 397